Relation of Biomarkers of Cardiac Injury, Stress, and Fibrosis with Cardiac Mechanics in Individuals ≥ 65 Years of Age.

[1]  Sanjiv J. Shah,et al.  Association of Cardiovascular Biomarkers With Incident Heart Failure With Preserved and Reduced Ejection Fraction , 2018, JAMA cardiology.

[2]  B. Psaty,et al.  Soluble ST2 for Prediction of Heart Failure and Cardiovascular Death in an Elderly, Community‐Dwelling Population , 2016, Journal of the American Heart Association.

[3]  A. Althouse.  Adjust for Multiple Comparisons? It's Not That Simple. , 2016, The Annals of thoracic surgery.

[4]  Sanjiv J. Shah,et al.  Archeological Echocardiography: Digitization and Speckle Tracking Analysis of Archival Echocardiograms in the HyperGEN Study , 2016, Echocardiography.

[5]  Thomas J. Wang,et al.  Soluble ST2 testing in the general population. , 2015, The American journal of cardiology.

[6]  C. O'connor,et al.  Prognostic Value of Baseline and Changes in Circulating Soluble ST2 Levels and the Effects of Nesiritide in Acute Decompensated Heart Failure. , 2015, JACC. Heart failure.

[7]  C. Ayers,et al.  Age- and sex-dependent upper reference limits for the high-sensitivity cardiac troponin T assay. , 2014, Journal of the American College of Cardiology.

[8]  J. Gottdiener,et al.  Long-term trajectory of two unique cardiac biomarkers and subsequent left ventricular structural pathology and risk of incident heart failure in community-dwelling older adults at low baseline risk. , 2013, JACC. Heart failure.

[9]  D. Levy,et al.  Prognostic Utility of Novel Biomarkers of Cardiovascular Stress: The Framingham Heart Study , 2012, Circulation.

[10]  Pawan K. Singal,et al.  The utility of cardiac biomarkers, tissue velocity and strain imaging, and cardiac magnetic resonance imaging in predicting early left ventricular dysfunction in patients with human epidermal growth factor receptor II-positive breast cancer treated with adjuvant trastuzumab therapy. , 2011, Journal of the American College of Cardiology.

[11]  M. Zhan,et al.  Association of serial measures of cardiac troponin T using a sensitive assay with incident heart failure and cardiovascular mortality in older adults. , 2010, JAMA.

[12]  T. Mueller,et al.  Long-term stability of soluble ST2 in frozen plasma samples. , 2010, Clinical biochemistry.

[13]  A. Wu,et al.  Multi-center determination of galectin-3 assay performance characteristics: Anatomy of a novel assay for use in heart failure. , 2010, Clinical biochemistry.

[14]  J. Gottdiener,et al.  Dynamic cardiovascular risk assessment in elderly people. The role of repeated N-terminal pro-B-type natriuretic peptide testing. , 2010, Journal of the American College of Cardiology.

[15]  M. Pfeffer,et al.  A sensitive cardiac troponin T assay in stable coronary artery disease. , 2009, The New England journal of medicine.

[16]  Tobias Reichlin,et al.  Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. , 2009, The New England journal of medicine.

[17]  T. Mueller,et al.  Analytical and clinical evaluation of a novel high-sensitivity assay for measurement of soluble ST2 in human plasma--the Presage ST2 assay. , 2009, Clinica chimica acta; international journal of clinical chemistry.

[18]  A. Lavoinne,et al.  Two-year stability of NT-proBNP in frozen samples using the Roche Elecsys system , 2008, Annals of clinical biochemistry.

[19]  A. Jaffe,et al.  The clinical need for high-sensitivity cardiac troponin assays for acute coronary syndromes and the role for serial testing. , 2008, American heart journal.

[20]  Hugo A. Katus,et al.  Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. , 2000, European heart journal.

[21]  R. Kronmal,et al.  The Cardiovascular Health Study: design and rationale. , 1991, Annals of epidemiology.

[22]  K J Rothman,et al.  No Adjustments Are Needed for Multiple Comparisons , 1990, Epidemiology.

[23]  T. Mueller,et al.  One-year in vitro stability of cardiac troponins and galectin-3 in different sample types. , 2018, Clinica chimica acta; international journal of clinical chemistry.

[24]  R. D. de Boer,et al.  Galectin-3 in Heart Failure: An Update of the Last 3 Years. , 2018, Heart failure clinics.

[25]  Sanjiv J Shah,et al.  Ultrastructural and cellular basis for the development of abnormal myocardial mechanics during the transition from hypertension to heart failure. , 2014, American journal of physiology. Heart and circulatory physiology.

[26]  H. S. Klopfenstein,et al.  Echocardiographic design of a multicenter investigation of free-living elderly subjects: the Cardiovascular Health Study. , 1992, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[27]  N. K. Jerne,et al.  The stability of biological standards. , 1956, Bulletin of the World Health Organization.